— U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover’s RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform — — Evaluation of SCB-1019 as part of a respiratory combination Trimer-Tagged PreF vaccine […]
Tag: Clover Biopharma
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK’s AREXVY
— Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) — — RSV neutralizing antibodies for Clover’s non-adjuvanted SCB-1019 matched GSK’s AS01E-adjuvanted AREXVY in older […]